What is TOBI?
TOBI XI is our 11th Annual gathering of orthobiologics thought-leaders from around the globe. Attending TOBI puts you on the cutting edge with the latest research and clinical pearls in orthopedic biologics. Join us to be informed and build relationships with the TOBI community of physicians, researchers and scientists on the forefront of orthopedics.
Knee Osteoarthritis is the leading cause of degenerative joint disease leading to joint dysfunction and pain. Both, intra-articular injections of PRP and HA have demonstrated effective long-term clinical management of pain symptoms and improving functionality. In 2015, as systematic review was published opposing the application of HA to treat knee osteoarthritis. Researchers Wu et al [...]
Osteonecrosis of the femoral head commonly affects patients between the age of 30 to 50 years and can lead to degeneration of the hip joint. A number of risk factors have been identified, including trauma to the hip joint, long-term use of corticosteroids, alcoholism, smoking, and more recently, organ transplantation, HIV infection, and autoimmune disease. [...]
Researchers at Emory University in Atlanta, Georgia are concerned about the validity of physical examinations of ACL tears in acute care settings. This article investigates ultrasound findings in acute ACL ruptures, which have historically been poorly diagnosed in acute care settings, such as the emergency room. The significance of this evidence-based inquiry will off-set the [...]
On June 8-9, 2018, field leaders in orthopedics and regenerative medicine from around the world gathered to present new research, data, and best practices. These world-class physicians and surgeons lectured and debated on regenerative medicine topics such as PRP, bone marrow concentrate (BMC), lipoaspirate, spine, biologics in orthopedic surgery, sports medicine, and regulatory issues.The abstracts [...]